Europe, CIS & Africa Spatial Transcriptomics Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Technology (Sequencing-based Methods, IHC), By Workflow, By Sample Type, By End-use, By Country, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within Immediate
Europe, CIS & Africa Spatial Transcriptomics Market Growth & Trends
The Europe, CIS & Africa spatial transcriptomics market size is anticipated t%li%reach USD 256.1 million by 2030, growing at a CAGR of 15.57% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The emerging potential of spatial omics analysis for cancer research, the advent of the fourth generation of sequencing (in situ sequencing), and increasing funding & collaborative initiatives in spatial biology research are likely t%li%contribute t%li%market growth. Moreover, the growing prevalence of chronic diseases necessitates efficient biomarker discovery and early & accurate diagnosis for effective disease management and treatment.
The spatial biology field has observed rapid development in the past few years. Commercial advancements in spatial multiomics methods, with increased capacity, multiplexity, and improved resolution, are some of the factors driving market growth. New instruments with higher multiplexing capabilities and resolution are enabling researchers t%li%obtain more detailed insights from spatial analyses. End-to-end scalable and reproducible workflows make it easier for researchers t%li%conduct spatial analysis efficiently. In addition, ongoing developments in the field are expected t%li%further accelerate the integration of spatial biology int%li%various stages of the drug discovery pipeline.
Furthermore, spatial omics analysis enables the identification of spatially resolved molecular signatures that can serve as potential biomarkers for cancer diagnosis and prognosis. By analyzing the spatial distribution of specific molecules within the tumor microenvironment, researchers can uncover novel biomarkers that may not be detectable using traditional omics approaches. In addition, by understanding the spatial organization of different cell populations and their interactions, clinicians can tailor treatment regimens t%li%target specific subpopulations more effectively within a tumor. For instance, according t%li%an article published in The Lancet in October 2022, scientists studied tissue architecture in Esophageal Squamous Cell Carcinoma (ESCC) by integrating microarray-based spatial transcriptomics and single-cell RNA sequencing.
The COVID-19 pandemic significantly impacted the market, with disruptions in supply chains and manufacturing processes leading t%li%shortages and delays in manufacturing timelines. However, post-pandemic advancements in bioinformatics and computational biology have simplified the interpretation of complex datasets generated by ST, expanding its applications across various industries such as pharmaceuticals, biotechnology, and research institutions. Furthermore, the heightened awareness and interest in medical research due t%li%the pandemic have further boosted the growth of the market.
However, one significant restraint of the market is the high cost associated with the technologies and instruments required for spatially resolved molecular profiling. The expense of acquiring and maintaining these advanced instruments can pose a barrier t%li%entry for researchers and healthcare providers, especially those operating in resource-constrained environments. This financial challenge may limit access t%li%innovative spatial transcriptomic technologies, hindering research progress and potentially impeding advancements in personalized medicine & disease understanding.
Europe, CIS & Africa Spatial Transcriptomics Market Report Highlights
Europe, CIS & Africa Spatial Transcriptomics Market Growth & Trends
The Europe, CIS & Africa spatial transcriptomics market size is anticipated t%li%reach USD 256.1 million by 2030, growing at a CAGR of 15.57% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The emerging potential of spatial omics analysis for cancer research, the advent of the fourth generation of sequencing (in situ sequencing), and increasing funding & collaborative initiatives in spatial biology research are likely t%li%contribute t%li%market growth. Moreover, the growing prevalence of chronic diseases necessitates efficient biomarker discovery and early & accurate diagnosis for effective disease management and treatment.
The spatial biology field has observed rapid development in the past few years. Commercial advancements in spatial multiomics methods, with increased capacity, multiplexity, and improved resolution, are some of the factors driving market growth. New instruments with higher multiplexing capabilities and resolution are enabling researchers t%li%obtain more detailed insights from spatial analyses. End-to-end scalable and reproducible workflows make it easier for researchers t%li%conduct spatial analysis efficiently. In addition, ongoing developments in the field are expected t%li%further accelerate the integration of spatial biology int%li%various stages of the drug discovery pipeline.
Furthermore, spatial omics analysis enables the identification of spatially resolved molecular signatures that can serve as potential biomarkers for cancer diagnosis and prognosis. By analyzing the spatial distribution of specific molecules within the tumor microenvironment, researchers can uncover novel biomarkers that may not be detectable using traditional omics approaches. In addition, by understanding the spatial organization of different cell populations and their interactions, clinicians can tailor treatment regimens t%li%target specific subpopulations more effectively within a tumor. For instance, according t%li%an article published in The Lancet in October 2022, scientists studied tissue architecture in Esophageal Squamous Cell Carcinoma (ESCC) by integrating microarray-based spatial transcriptomics and single-cell RNA sequencing.
The COVID-19 pandemic significantly impacted the market, with disruptions in supply chains and manufacturing processes leading t%li%shortages and delays in manufacturing timelines. However, post-pandemic advancements in bioinformatics and computational biology have simplified the interpretation of complex datasets generated by ST, expanding its applications across various industries such as pharmaceuticals, biotechnology, and research institutions. Furthermore, the heightened awareness and interest in medical research due t%li%the pandemic have further boosted the growth of the market.
However, one significant restraint of the market is the high cost associated with the technologies and instruments required for spatially resolved molecular profiling. The expense of acquiring and maintaining these advanced instruments can pose a barrier t%li%entry for researchers and healthcare providers, especially those operating in resource-constrained environments. This financial challenge may limit access t%li%innovative spatial transcriptomic technologies, hindering research progress and potentially impeding advancements in personalized medicine & disease understanding.
Europe, CIS & Africa Spatial Transcriptomics Market Report Highlights
- Consumables dominated the product segment in 2023 owing t%li%the high product penetration, increasing use of reagents & kits, wide product availability, and frequent purchase of consumables t%li%run instruments.
- In 2023, sequencing-based methods dominated the technology segment and held the largest revenue share in 2023. Furthermore, the microscopy-based RNA imaging techniques segment is expected t%li%grow at a significant CAGR over the forecast period.
- On the basis of workflow, the sample preparation segment held the largest revenue share of 55.49% in 2023 as it is crucial for obtaining high-quality sequencing products for performing genomics & transcriptomics studies.
- The FFPE segment dominated the sample type segment in terms of revenue in 2023. New techniques are devised for gene expression profiling in FFPE that further drive segment growth. However, the fresh frozen segment is anticipated t%li%grow at the highest CAGR of 17.14% from 2024 t%li%2030.
- Translational research dominated the end use market with the largest share in 2023. By mapping gene expression patterns within tissues, spatial transcriptomics helps understand molecular mechanisms underlying disease pathogenesis. Researchers can identify key genes and pathways associated with specific diseases, leading t%li%the discovery of potential therapeutic targets.
- Europe region dominated the market with a share of 94.57% in 2023, owing t%li%factors such as increasing investments in R&D activities, established biotechnology R&D sector, and presence of key players.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Technology Segment
1.2.3. Workflow Segment
1.2.4. Sample Type
1.2.5. End Use Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. EUROPE, CIS & AFRICA SPATIAL TRANSCRIPTOMICS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Emerging potential of spatial omics in cancer research
3.2.1.2. Advent of the fourth generation of sequencing (in-situ sequencing)
3.2.1.3. Increasing funding and collaborative initiatives in spatial biology research
3.2.2. Market restraint analysis
3.2.2.1. High cost of instruments
3.3. Spatial Transcriptomics Market Analysis Tools
3.3.1. Industry Analysis – Porter’s Five Forces
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. EUROPE, CIS & AFRICA SPATIAL TRANSCRIPTOMICS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Europe, CIS & Africa Spatial Transcriptomics Market Product Movement Analysis
4.3. Europe, CIS & Africa Spatial Transcriptomics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Instruments
4.4.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Mode
4.4.2.1. Automated
4.4.2.2. Automated market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.3. Semi-automated
4.4.2.4. Semi-automated market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.5. Manual
4.4.2.6. Manual market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Type
4.4.3.1. Sequencing Platforms
4.4.3.2. Sequencing platforms market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.3. IHC
4.4.3.4. IHC market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.5. Microscopy
4.4.3.6. Microscopy market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.7. Flow Cytometry
4.4.3.8. Flow cytometry market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.9. Mass Spectrometry
4.4.3.10. Mass spectrometry market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.11. Others
4.4.3.12. Others market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Consumables
4.5.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Software
4.6.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Bioinformatics Tools
4.6.2.1. Bioinformatics tools market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Imaging Tools
4.6.3.1. Imaging tools market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Storage and Management Databases
4.6.4.1. Storage and management databases market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. EUROPE, CIS & AFRICA SPATIAL TRANSCRIPTOMICS MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Europe, CIS & Africa Spatial Transcriptomics Market Technology Movement Analysis
5.3. Europe, CIS & Africa Spatial Transcriptomics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. Sequencing-based Methods
5.4.1. Laser Capture Microdissection
5.4.1.1. Laser capture microdissection market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Transcriptome In-vivo Analysis (TIVA)
5.4.2.1. Transcriptome in-vivo analysis market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. In-situ Sequencing
5.4.3.1. In-situ sequencing market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Microtomy Sequencing
5.4.4.1. Microtomy sequencing market estimates and forecasts 2018 to 2030 (USD Million)
5.5. IHC
5.6. Microscopy-based RNA Imaging Techniques
5.6.1. Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH)
5.6.1.1. Single molecule RNA in-situ hybridization (smFISH) market estimates and forecasts 2018 to 2030 (USD Million)
5.6.2. Padlock Probes & Rolling Circle Amplification
5.6.2.1. Padlock probes & rolling circle amplification market estimates and forecasts 2018 to 2030 (USD Million)
5.6.3. Branched DNA Probes
5.6.3.1. Branched DNA probes market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. EUROPE, CIS & AFRICA SPATIAL TRANSCRIPTOMICS MARKET: WORKFLOW ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Europe, CIS & Africa Spatial Transcriptomics Market Workflow Movement Analysis
6.3. Europe, CIS & Africa Spatial Transcriptomics Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
6.4. Sample Preparation
6.4.1. Sample preparation market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Instrumental Analysis
6.5.1. Instrumental analysis market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Data Analysis
6.6.1. Data analysis market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. EUROPE, CIS & AFRICA SPATIAL TRANSCRIPTOMICS MARKET: SAMPLE TYPE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Europe, CIS & Africa Spatial Transcriptomics Market Sample Type Movement Analysis
7.3. Europe, CIS & Africa Spatial Transcriptomics Market Size & Trend Analysis, by Sample Type, 2018 to 2030 (USD Million)
7.4. FFPE
7.4.1. FFPE market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Fresh Frozen
7.5.1. Fresh frozen market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. EUROPE, CIS & AFRICA SPATIAL TRANSCRIPTOMICS MARKET: END USE ESTIMATES & TREND ANALYSIS
8.1. Segment Dashboard
8.2. Europe, CIS & Africa Spatial Transcriptomics Market End Use Movement Analysis
8.3. Europe, CIS & Africa Spatial Transcriptomics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Translational Research
8.4.1. Translational research market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Academic Customers
8.5.1. Academic customers market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Diagnostic Customers
8.6.1. Diagnostic customers market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Pharmaceutical manufacturer
8.7.1. Pharmaceutical manufacturer market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 9. EUROPE, CIS & AFRICA SPATIAL TRANSCRIPTOMICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
9.1. Regional Market Share Analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.4.1.3. Competitive scenario
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.4.2.3. Competitive scenario
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. France market estimates and forecasts 2018 to 2030 (USD Million)
9.4.3.3. Competitive scenario
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.4.4.3. Competitive scenario
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.4.5.3. Competitive scenario
9.4.6. Denmark
9.4.6.1. Key country dynamics
9.4.6.2. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.4.6.3. Competitive scenario
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.4.7.3. Competitive scenario
9.4.8. Norway
9.4.8.1. Key country dynamics
9.4.8.2. 4Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.4.8.3. Competitive scenario
9.4.9. Netherlands
9.4.9.1. Key country dynamics
9.4.9.2. Netherlands market estimates and forecasts 2018 to 2030 (USD Million)
9.4.9.3. Competitive scenario
9.4.10. Belgium
9.4.10.1. Key country dynamics
9.4.10.2. Belgium market estimates and forecasts 2018 to 2030 (USD Million)
9.4.10.3. Competitive scenario
9.4.11. Finland
9.4.11.1. Key country dynamics
9.4.11.2. Finland market estimates and forecasts 2018 to 2030 (USD Million)
9.4.11.3. Competitive scenario
9.4.12. Switzerland
9.4.12.1. Key country dynamics
9.4.12.2. Switzerland market estimates and forecasts 2018 to 2030 (USD Million)
9.4.12.3. Competitive scenario
9.4.13. Poland
9.4.13.1. Key country dynamics
9.4.13.2. Poland market estimates and forecasts 2018 to 2030 (USD Million)
9.4.13.3. Competitive scenario
9.5. Latin America
9.6. MEA
9.6.1. South Africa
9.6.1.1. Key country dynamics
9.6.1.2. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.6.1.3. Competitive scenario
9.6.2. Nigeria
9.6.2.1. Key country dynamics
9.6.2.2. Nigeria market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2.3. Competitive scenario
9.6.3. Morocco
9.6.3.1. Key country dynamics
9.6.3.2. Morocco market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3.3. Competitive scenario
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2023
10.4. Company Profiles/Listing
10.4.1. Illumina, Inc.
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Bruker
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. 10X Genomics
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. EdenRoc Sciences (Cantata Bio, LLC)
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Shimadzu Corporation
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Waters Corporation
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Bio-Techne
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. Vizgen Inc.
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Spatial Genomics
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.10. Akoya Biosciences, Inc.
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Technology Segment
1.2.3. Workflow Segment
1.2.4. Sample Type
1.2.5. End Use Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. EUROPE, CIS & AFRICA SPATIAL TRANSCRIPTOMICS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Emerging potential of spatial omics in cancer research
3.2.1.2. Advent of the fourth generation of sequencing (in-situ sequencing)
3.2.1.3. Increasing funding and collaborative initiatives in spatial biology research
3.2.2. Market restraint analysis
3.2.2.1. High cost of instruments
3.3. Spatial Transcriptomics Market Analysis Tools
3.3.1. Industry Analysis – Porter’s Five Forces
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. EUROPE, CIS & AFRICA SPATIAL TRANSCRIPTOMICS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Europe, CIS & Africa Spatial Transcriptomics Market Product Movement Analysis
4.3. Europe, CIS & Africa Spatial Transcriptomics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Instruments
4.4.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Mode
4.4.2.1. Automated
4.4.2.2. Automated market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.3. Semi-automated
4.4.2.4. Semi-automated market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.5. Manual
4.4.2.6. Manual market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Type
4.4.3.1. Sequencing Platforms
4.4.3.2. Sequencing platforms market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.3. IHC
4.4.3.4. IHC market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.5. Microscopy
4.4.3.6. Microscopy market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.7. Flow Cytometry
4.4.3.8. Flow cytometry market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.9. Mass Spectrometry
4.4.3.10. Mass spectrometry market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.11. Others
4.4.3.12. Others market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Consumables
4.5.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Software
4.6.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Bioinformatics Tools
4.6.2.1. Bioinformatics tools market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Imaging Tools
4.6.3.1. Imaging tools market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Storage and Management Databases
4.6.4.1. Storage and management databases market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. EUROPE, CIS & AFRICA SPATIAL TRANSCRIPTOMICS MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Europe, CIS & Africa Spatial Transcriptomics Market Technology Movement Analysis
5.3. Europe, CIS & Africa Spatial Transcriptomics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. Sequencing-based Methods
5.4.1. Laser Capture Microdissection
5.4.1.1. Laser capture microdissection market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Transcriptome In-vivo Analysis (TIVA)
5.4.2.1. Transcriptome in-vivo analysis market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. In-situ Sequencing
5.4.3.1. In-situ sequencing market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Microtomy Sequencing
5.4.4.1. Microtomy sequencing market estimates and forecasts 2018 to 2030 (USD Million)
5.5. IHC
5.6. Microscopy-based RNA Imaging Techniques
5.6.1. Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH)
5.6.1.1. Single molecule RNA in-situ hybridization (smFISH) market estimates and forecasts 2018 to 2030 (USD Million)
5.6.2. Padlock Probes & Rolling Circle Amplification
5.6.2.1. Padlock probes & rolling circle amplification market estimates and forecasts 2018 to 2030 (USD Million)
5.6.3. Branched DNA Probes
5.6.3.1. Branched DNA probes market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. EUROPE, CIS & AFRICA SPATIAL TRANSCRIPTOMICS MARKET: WORKFLOW ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Europe, CIS & Africa Spatial Transcriptomics Market Workflow Movement Analysis
6.3. Europe, CIS & Africa Spatial Transcriptomics Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
6.4. Sample Preparation
6.4.1. Sample preparation market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Instrumental Analysis
6.5.1. Instrumental analysis market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Data Analysis
6.6.1. Data analysis market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. EUROPE, CIS & AFRICA SPATIAL TRANSCRIPTOMICS MARKET: SAMPLE TYPE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Europe, CIS & Africa Spatial Transcriptomics Market Sample Type Movement Analysis
7.3. Europe, CIS & Africa Spatial Transcriptomics Market Size & Trend Analysis, by Sample Type, 2018 to 2030 (USD Million)
7.4. FFPE
7.4.1. FFPE market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Fresh Frozen
7.5.1. Fresh frozen market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. EUROPE, CIS & AFRICA SPATIAL TRANSCRIPTOMICS MARKET: END USE ESTIMATES & TREND ANALYSIS
8.1. Segment Dashboard
8.2. Europe, CIS & Africa Spatial Transcriptomics Market End Use Movement Analysis
8.3. Europe, CIS & Africa Spatial Transcriptomics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Translational Research
8.4.1. Translational research market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Academic Customers
8.5.1. Academic customers market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Diagnostic Customers
8.6.1. Diagnostic customers market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Pharmaceutical manufacturer
8.7.1. Pharmaceutical manufacturer market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 9. EUROPE, CIS & AFRICA SPATIAL TRANSCRIPTOMICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
9.1. Regional Market Share Analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.4.1.3. Competitive scenario
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.4.2.3. Competitive scenario
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. France market estimates and forecasts 2018 to 2030 (USD Million)
9.4.3.3. Competitive scenario
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.4.4.3. Competitive scenario
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.4.5.3. Competitive scenario
9.4.6. Denmark
9.4.6.1. Key country dynamics
9.4.6.2. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.4.6.3. Competitive scenario
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.4.7.3. Competitive scenario
9.4.8. Norway
9.4.8.1. Key country dynamics
9.4.8.2. 4Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.4.8.3. Competitive scenario
9.4.9. Netherlands
9.4.9.1. Key country dynamics
9.4.9.2. Netherlands market estimates and forecasts 2018 to 2030 (USD Million)
9.4.9.3. Competitive scenario
9.4.10. Belgium
9.4.10.1. Key country dynamics
9.4.10.2. Belgium market estimates and forecasts 2018 to 2030 (USD Million)
9.4.10.3. Competitive scenario
9.4.11. Finland
9.4.11.1. Key country dynamics
9.4.11.2. Finland market estimates and forecasts 2018 to 2030 (USD Million)
9.4.11.3. Competitive scenario
9.4.12. Switzerland
9.4.12.1. Key country dynamics
9.4.12.2. Switzerland market estimates and forecasts 2018 to 2030 (USD Million)
9.4.12.3. Competitive scenario
9.4.13. Poland
9.4.13.1. Key country dynamics
9.4.13.2. Poland market estimates and forecasts 2018 to 2030 (USD Million)
9.4.13.3. Competitive scenario
9.5. Latin America
9.6. MEA
9.6.1. South Africa
9.6.1.1. Key country dynamics
9.6.1.2. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.6.1.3. Competitive scenario
9.6.2. Nigeria
9.6.2.1. Key country dynamics
9.6.2.2. Nigeria market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2.3. Competitive scenario
9.6.3. Morocco
9.6.3.1. Key country dynamics
9.6.3.2. Morocco market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3.3. Competitive scenario
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2023
10.4. Company Profiles/Listing
10.4.1. Illumina, Inc.
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Bruker
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. 10X Genomics
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. EdenRoc Sciences (Cantata Bio, LLC)
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Shimadzu Corporation
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Waters Corporation
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Bio-Techne
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. Vizgen Inc.
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Spatial Genomics
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.10. Akoya Biosciences, Inc.
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 Europe, CIS & Africa spatial transcriptomics market, by region, 2018 - 2030 (USD Million)
Table 3 Europe, CIS & Africa spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 4 Europe, CIS & Africa spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 5 Europe, CIS & Africa spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 6 Europe, CIS & Africa spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 7 Europe, CIS & Africa spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 8 Europe spatial transcriptomics market, by country, 2018 - 2030 (USD Million)
Table 9 Europe spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 10 Europe spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 11 Europe spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 12 Europe spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 13 Europe spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 14 UK spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 15 UK spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 16 UK spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 17 UK spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 18 UK spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 19 Germany spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 20 Germany spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 21 Germany spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 22 Germany spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 23 Germany spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 24 France spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 25 France spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 26 France spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 27 France spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 28 France spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 29 Italy spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 30 Italy spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 31 Italy spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 32 Italy spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 33 Italy spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 34 Spain spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 35 Spain spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 36 Spain spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 37 Spain spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 38 Spain spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 39 Denmark spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 40 Denmark spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 41 Denmark spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 42 Denmark spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 43 Denmark spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 44 Sweden spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 45 Sweden spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 46 Sweden spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 47 Sweden spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 48 Sweden spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 49 Norway spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 50 Norway spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 51 Norway spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 52 Norway spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 53 Norway spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 54 Netherlands spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 55 Netherlands spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 56 Netherlands spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 57 Netherlands spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 58 Netherlands spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 59 Belgium spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 60 Belgium spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 61 Belgium spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 62 Belgium spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 63 Belgium spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 64 Finland spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 65 Finland spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 66 Finland spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 67 Finland spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 68 Finland spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 69 Switzerland spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 70 Switzerland spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 71 Switzerland spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 72 Switzerland spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 73 Switzerland spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 74 Poland spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 75 Poland spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 76 Poland spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 77 Poland spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 78 Poland spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 79 CIS spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 80 CIS spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 81 CIS spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 82 CIS spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 83 CIS spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 84 Africa spatial transcriptomics market, by country, 2018 - 2030 (USD Million)
Table 85 Africa spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 86 Africa spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 87 Africa spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 88 Africa spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 89 Africa spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 90 South Africa spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 91 South Africa spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 92 South Africa spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 93 South Africa spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 94 South Africa spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 95 Nigeria spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 96 Nigeria spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 97 Nigeria spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 98 Nigeria spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 99 Nigeria spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 100 Morocco spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 101 Morocco spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 102 Morocco spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 103 Morocco spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 104 Morocco spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 1 List of abbreviations
Table 2 Europe, CIS & Africa spatial transcriptomics market, by region, 2018 - 2030 (USD Million)
Table 3 Europe, CIS & Africa spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 4 Europe, CIS & Africa spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 5 Europe, CIS & Africa spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 6 Europe, CIS & Africa spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 7 Europe, CIS & Africa spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 8 Europe spatial transcriptomics market, by country, 2018 - 2030 (USD Million)
Table 9 Europe spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 10 Europe spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 11 Europe spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 12 Europe spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 13 Europe spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 14 UK spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 15 UK spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 16 UK spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 17 UK spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 18 UK spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 19 Germany spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 20 Germany spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 21 Germany spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 22 Germany spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 23 Germany spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 24 France spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 25 France spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 26 France spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 27 France spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 28 France spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 29 Italy spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 30 Italy spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 31 Italy spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 32 Italy spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 33 Italy spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 34 Spain spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 35 Spain spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 36 Spain spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 37 Spain spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 38 Spain spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 39 Denmark spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 40 Denmark spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 41 Denmark spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 42 Denmark spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 43 Denmark spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 44 Sweden spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 45 Sweden spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 46 Sweden spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 47 Sweden spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 48 Sweden spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 49 Norway spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 50 Norway spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 51 Norway spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 52 Norway spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 53 Norway spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 54 Netherlands spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 55 Netherlands spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 56 Netherlands spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 57 Netherlands spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 58 Netherlands spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 59 Belgium spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 60 Belgium spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 61 Belgium spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 62 Belgium spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 63 Belgium spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 64 Finland spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 65 Finland spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 66 Finland spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 67 Finland spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 68 Finland spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 69 Switzerland spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 70 Switzerland spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 71 Switzerland spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 72 Switzerland spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 73 Switzerland spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 74 Poland spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 75 Poland spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 76 Poland spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 77 Poland spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 78 Poland spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 79 CIS spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 80 CIS spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 81 CIS spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 82 CIS spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 83 CIS spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 84 Africa spatial transcriptomics market, by country, 2018 - 2030 (USD Million)
Table 85 Africa spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 86 Africa spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 87 Africa spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 88 Africa spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 89 Africa spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 90 South Africa spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 91 South Africa spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 92 South Africa spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 93 South Africa spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 94 South Africa spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 95 Nigeria spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 96 Nigeria spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 97 Nigeria spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 98 Nigeria spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 99 Nigeria spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
Table 100 Morocco spatial transcriptomics market, by product, 2018 - 2030 (USD Million)
Table 101 Morocco spatial transcriptomics market, by technology, 2018 - 2030 (USD Million)
Table 102 Morocco spatial transcriptomics market, by workflow, 2018 - 2030 (USD Million)
Table 103 Morocco spatial transcriptomics market, by sample type, 2018 - 2030 (USD Million)
Table 104 Morocco spatial transcriptomics market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Market segmentation
Fig. 8 Market snapshot
Fig. 9 Segment snapshot
Fig. 10 Competitive landscape snapshot
Fig. 11 Market trends & outlook
Fig. 12 Market driver relevance analysis (current & future impact)
Fig. 13 Market restraint relevance analysis (current & future impact)
Fig. 14 PESTLE analysis
Fig. 15 Porter’s Five Forces analysis
Fig. 16 Hormonal contraceptive market: Method outlook and key takeaways
Fig. 17 Hormonal contraceptive market: Method movement analysis
Fig. 18 Pill market revenue, 2018 - 2030 (USD Million)
Fig. 19 IUD market revenue, 2018 - 2030 (USD Million)
Fig. 20 Injectable market revenue, 2018 - 2030 (USD Million)
Fig. 21 Vaginal ring market revenue, 2018 - 2030 (USD Million)
Fig. 22 Implant market revenue, 2018 - 2030 (USD Million)
Fig. 23 Patch market revenue, 2018 - 2030 (USD Million)
Fig. 24 Hormonal contraceptive market: Hormone outlook and key takeaways
Fig. 25 Hormonal contraceptive market: Hormone movement analysis
Fig. 26 Combined hormone contraceptive market revenue, 2018 - 2030 (USD Million)
Fig. 27 Progestin only market revenue, 2018 - 2030 (USD Million)
Fig. 28 Regional marketplace: Key takeaways
Fig. 29 Regional outlook, 2023 & 2030
Fig. 30 Hormonal contraceptive market: Region movement analysis
Fig. 31 North America hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 32 US hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 33 Key country dynamics
Fig. 34 Canada hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 35 Key country dynamics
Fig. 36 Mexico hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 37 Key country dynamics
Fig. 38 Europe hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 39 Germany hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 40 Key country dynamics
Fig. 41 UK hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 42 Key country dynamics
Fig. 43 France hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 Italy hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 Spain hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 Sweden hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Norway hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 Denmark hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 Asia Pacific hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 56 Japan hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 China hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 India hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Australia hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 South Korea hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Thailand hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Latin America hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 69 Brazil hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Argentina hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Middle East and Africa hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 74 South Africa hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Saudi Arabia hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 UAE hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Kuwait hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Company categorization
Fig. 83 Strategy mapping
Fig. 84 Company market position analysis
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Market segmentation
Fig. 8 Market snapshot
Fig. 9 Segment snapshot
Fig. 10 Competitive landscape snapshot
Fig. 11 Market trends & outlook
Fig. 12 Market driver relevance analysis (current & future impact)
Fig. 13 Market restraint relevance analysis (current & future impact)
Fig. 14 PESTLE analysis
Fig. 15 Porter’s Five Forces analysis
Fig. 16 Hormonal contraceptive market: Method outlook and key takeaways
Fig. 17 Hormonal contraceptive market: Method movement analysis
Fig. 18 Pill market revenue, 2018 - 2030 (USD Million)
Fig. 19 IUD market revenue, 2018 - 2030 (USD Million)
Fig. 20 Injectable market revenue, 2018 - 2030 (USD Million)
Fig. 21 Vaginal ring market revenue, 2018 - 2030 (USD Million)
Fig. 22 Implant market revenue, 2018 - 2030 (USD Million)
Fig. 23 Patch market revenue, 2018 - 2030 (USD Million)
Fig. 24 Hormonal contraceptive market: Hormone outlook and key takeaways
Fig. 25 Hormonal contraceptive market: Hormone movement analysis
Fig. 26 Combined hormone contraceptive market revenue, 2018 - 2030 (USD Million)
Fig. 27 Progestin only market revenue, 2018 - 2030 (USD Million)
Fig. 28 Regional marketplace: Key takeaways
Fig. 29 Regional outlook, 2023 & 2030
Fig. 30 Hormonal contraceptive market: Region movement analysis
Fig. 31 North America hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 32 US hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 33 Key country dynamics
Fig. 34 Canada hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 35 Key country dynamics
Fig. 36 Mexico hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 37 Key country dynamics
Fig. 38 Europe hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 39 Germany hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 40 Key country dynamics
Fig. 41 UK hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 42 Key country dynamics
Fig. 43 France hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 Italy hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 Spain hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 Sweden hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Norway hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 Denmark hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 Asia Pacific hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 56 Japan hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 China hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 India hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Australia hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 South Korea hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Thailand hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Latin America hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 69 Brazil hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Argentina hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Middle East and Africa hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 74 South Africa hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Saudi Arabia hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 UAE hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Kuwait hormonal contraceptive market, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Company categorization
Fig. 83 Strategy mapping
Fig. 84 Company market position analysis
